Articles for category: Most Popular

The whipping post

Nasdaq 100: Will Nvidia's Earnings Prick the AI Bubble?

Nasdaq 100 Key Points NVDA has “beat” analyst estimates for earnings in seven of the last eight quarters by an overall average of 15%, rising an average of more than 9% in response to those results Implied volatility on options suggesting that we could see a +/- 9% move in response to Nvidia’s earnings report. ...

The whipping post

This Is Why NVIDIA Joined the Dow; And Why It's Time to Buy

NVIDIA Corporation’s NVDA graphic processing units (GPU) were once sought-after among gamers but are now the key players in the artificial intelligence (AI) market, leading to the company being added to the Dow Jones Industrial Average. Does this make NVIDIA an enticing buy, or is there more to watch closely before making a bet? Let’s ...

The whipping post

Companies Race to Deploy GenAI for Efficiency, Innovation

 Use cases grow rapidly as technology evolves, enterprises and providers craft models to meet specific business goals, ISG Provider Lens™ report says Global adoption of generative AI is growing rapidly, placing pressure on enterprises to invest in the technology to remain competitive, according to a new research report published today by Information Services Group (ISG) ...

The whipping post

Top 3 Financials Stocks That May Rocket Higher In Q4

The most oversold stocks in the financials sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better ...

The whipping post

Cathie Wood Redirects Elon Musk's DOGE Focus Toward Nuclear Energy Amid Regulatory Challenges: Here's How Oklo, Cameco, Centrus Energy And Other Stocks Performed

Nuclear energy stocks and ETFs have come to the fore as ARK Invest’s founder Cathie Wood reshared the firm’s study on how regulatory hurdles and anti-nuclear sentiment have caused cost overruns and rendered nuclear energy less cost-competitive than natural gas today. This comes as Tesla Inc. and SpaceX CEO Elon Musk is all set to ...

The whipping post

Should You Forget Bitcoin and Buy Dogecoin Instead?

Bitcoin‘s (CRYPTO: BTC) price has more than doubled during the past 12 months and is hovering near its all-time high. The approvals of its first spot price exchange-traded funds (ETFs) in January, its halving in April, two interest rate cuts, and Trump’s election victory brought back a stampede of bulls. But Dogecoin (CRYPTO: DOGE) — ...

The whipping post

3 Reasons to Buy Shopify Stock Like There's No Tomorrow

Are you looking for a new stock pick to capitalize on the market’s newfound strength? Consider stepping into a stake in Shopify (NYSE: SHOP). It’s a right place/right time kind of prospect… something all investors were reminded of Tuesday. Fortunately, it’s not too late to jump in. What’s Shopify? On the off-chance you’re reading this ...

The whipping post

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024

New preclinical results support the anti-fibrotic potential of engineered macrophages in multiple fibrosis models Engineered TIM4-expressing macrophages correct defective efferocytosis in MASH, demonstrating potent anti-fibrotic activity  PHILADELPHIA, Nov. 17, 2024 /PRNewswire/ — Carisma Therapeutics Inc. CARM (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today presented promising preclinical data on ...